Síndromes isquémicos coronarios agudos con elevación del segmento ST. La estrategiafarmacomecánica es el futuro del tratamiento universal? / ST elevation acute coronary syndromes. Pharmaco-mechanic strategy is the universal treatment future?
Arch. cardiol. Méx
;
76(supl.2): S252-S257, abr.-jun. 2006.
Article
Dans Espagnol
| LILACS
| ID: lil-568809
ABSTRACT
The main objective in the medical treatment of the ST elevation acute myocardial infarction, must have the intention to reperfuse the culprit involved artery. In order to reduce this time, the pharmaco-invasive strategy may offer rapid flow recanalization in the culprit artery and reduce the damage of the myocardium. The new pharmacologic combinations includes half dose of fibrinolytics, alone or in combination with IIb/IIIa inhibitors, this combination may offer advantages of the flow. This concept involves the that PCI (Percutaneous Coronary Interventions), can be done in a subsequent time. The risk of bleeding is increased with this strategy, and some evaluation or bleeding risk must be done in all patients, as in patients with 75 years and older.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Angioplastie coronaire par ballonnet
/
Angor instable
/
Infarctus du myocarde
Limites du sujet:
Humains
langue:
Espagnol
Texte intégral:
Arch. cardiol. Méx
Thème du journal:
Cardiologie
Année:
2006
Type:
Article
Pays d'affiliation:
Mexique
Institution/Pays d'affiliation:
Instituto Nacional de Cardiología Ignacio Chávez/MX
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS